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ABSTRACT
Objective This paper explores the issues that arise
from the discussion of administering rescue medication
to children who experience prolonged convulsive seizures
in mainstream schools in the UK.
Situation analysis Current guidelines recommend
immediate treatment of children with such seizures
(deﬁned as seizures lasting more than 5 min) to prevent
progression to status epilepticus and neurological
morbidity. As children are unconscious during prolonged
convulsive seizures, whether or not they receive their
treatment in time depends on the presence of a teacher
or other member of staff trained and able to administer
rescue medication. However, it is thought that the
situation varies between schools and depends mainly on
the goodwill and resources available locally.
Recommendations A more systematic response is
needed to ensure that children receive rescue medication
regardless of where their seizure occurs. Possible ways
forward include: greater use of training resources for
schools available from epilepsy voluntary sector
organisations; consistent, practical information to schools;
transparent guidance outlining a clear care pathway from
the hospital to the school; and implementation and
adherence to each child’s individual healthcare plan.
Implications Children requiring emergency treatment
for prolonged convulsive seizures during school hours test
the goals of integrated, person-centred care as well as
joined-up working to which the National Health Service
(NHS) aspires. As changes to the NHS come into play and
local services become reconﬁgured, every effort should be
made to take account of the particular needs of this
vulnerable group of children within broader efforts to
improve the quality of paediatric epilepsy services overall.
INTRODUCTION
Signiﬁcant shortfalls in service delivery for children
with epilepsy have recently been reported in the
UK.1 2 A particularly vulnerable group are children
who experience prolonged convulsive seizures,
deﬁned as seizures lasting 5 min or more.3 National
Institute for Health and Clinical Excellence (NICE)
guidelines4 recommend immediate treatment of
children with such seizures to prevent progression
to status epilepticus and neurological morbidity.5 6
Most seizures occur outside of the hospital setting.
Children are often unconscious during prolonged
convulsive seizures; thus, whether or not they
receive their treatment in time depends on the pres-
ence of a caregiver trained and able to administer
rescue medication. This paper explores the issues
that arise from the discussion of administering
rescue medication in mainstream schools in the UK
in the hope of raising awareness of unmet needs in
this area.
PROLONGED CONVULSIVE SEIZURES
IN CHILDREN
Seizures that last more than 5 min are unlikely to
stop on their own;7 thus, guidelines recommend
that rescue medication (buccal midazolam or, if
preferred or if buccal midazolam is unavailable,
rectal diazepam) be administered for any convulsive
seizure lasting 5 min or more in a community
setting.4 Delays in treatment increase the risk of
status epilepticus,8 which may result in possible
cognitive deﬁcits5 9 and even death.10
The NICE guidelines for the diagnosis and man-
agement of the epilepsies in primary and secondary
care recommend that all relevant caregivers, who
include parents, teachers and other school staff,
receive dedicated training to be able to administer
rescue medication as promptly as possible to children
according to a prespeciﬁed protocol.4 Guidance on
medicines management in mainstream schools also
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What is already known on this topic
▸ It is recommended that children who have
prolonged convulsive seizures receive rescue
medication as quickly as possible to avoid
progression to status epilepticus.
▸ Most seizures occur outside of the hospital
setting.
▸ Whether or not a child receives rescue
medication in time depends on the presence of
a trained caregiver.
What this study adds
▸ Whether or not a child receives rescue
medication at school depends on the resources
and training available at each individual school.
▸ Many schools will either rely on parents or call
an ambulance whenever a prolonged seizure
occurs, with clinical consequences for the child.
▸ Clear guidance linking educational and
healthcare sectors is needed for all children to
receive rescue medication for prolonged
seizures regardless of where they occur.
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exists within the educational sector; however, it is not speciﬁc to
the situation of children with prolonged convulsive seizures, and
thus recommendations are subject to interpretation (box 1).11–13
ARE SCHOOLS OBLIGED TO ADMINISTER RESCUE
MEDICATION TO CHILDREN?
In the UK, children with epilepsy are considered disabled for
the purposes of the Equality Act of 2010 and are thus protected
from discrimination in terms of admission and participation in
school activities.14 Under the Education and Inspections Act of
2006, schools must make all arrangements necessary to meet
the needs of any child requiring medical assistance during
school hours.15 However, it is not a legal requirement for
school staff to administer medicines to children (this role is
entirely voluntary). Most teachers’ unions actively discourage
their members from accepting responsibility for doing so claim-
ing that this falls outside of their duty of care and that they may
be liable if anything goes wrong.16 17
What happens in practice? Little published evidence exists on
the experience of children who require rescue medication at
school but the situation is thought to vary between schools.
Insights from epilepsy specialists suggest that schools often react
with panic and fear when faced with a child having a prolonged
convulsive seizure. Fear of liability is a major barrier to over-
come (PERFECT, data on ﬁle, 2012).
Some schools call an ambulance for every prolonged convul-
sive seizure that occurs at school, potentially causing treatment
delays and subsequent complications for the child.18 19 Others
may expect parents to be permanently on call in case their child
experiences a seizure during school hours, forcing many parents
to abandon full-time employment for the safety of their child.
Both situations may threaten the social integration of the child
and lead to stigmatisation.
Certain requirements must be met for the needs of these chil-
dren to be addressed during school hours, the most important
being training, clear information and communication, resources
and accountability.
TRAINING, INFORMATION, RESOURCES AND
ACCOUNTABILITY
Several studies point to inadequate training on epilepsy in
schools. A survey of schools carried out by Epilepsy Action in
2012 found that over a quarter had not received any epilepsy
training in the past 3 years.20 One in six teachers said that pupils
with epilepsy at their school either did not have an individual
healthcare plan or that they did not know if they had one.
Better information and communication to schools is the key.1
Charitable organisations, in particular Young Epilepsy, the Joint
Epilepsy Council and Epilepsy Action, have played an essential
role in providing helpful resources on rescue medication to
parents and schools in the form of guidance, templates and
training courses.21–23 But implementing training requires ﬁrm
commitment from staff volunteering to be trained as well as the
school. For example, the Joint Epilepsy Council recommends
two full days of training within school settings to ensure
competency.22
Resources outside of the educational system are also critical.
NICE recommends that every child with a diagnosis of epilepsy
should have a dedicated paediatric epilepsy specialist nurse
(ESN) who acts as the liaison to the child’s school and provides
support and training in the child’s home and school.4
Unfortunately, poor resourcing of paediatric ESNs is a long-
standing issue, despite their proven role in reducing the number
of admissions to hospital for children.24 In all, 47% of the
paediatric epilepsy centres audited in the Royal College of
Paediatrics and Child Health Epilepsy12 (2012) survey had no
ESNs.1 Without a dedicated ESN, parents are left as the sole
link between the health service and the educational system, yet
they may lack the necessary skills and information to fulﬁl such
a role.
The issue of accountability is also important. NICE guidelines
recommend that only children who have had a previous episode
of prolonged convulsive seizures should be prescribed rescue
medication. The implication of this ‘responsible prescribing’ is
that schools are only asked to invest in training to administer
rescue medication when they have a pupil who is known to be
at risk.
THE WAY FORWARD
Children requiring emergency treatment for prolonged convul-
sive seizures during school hours test the goals of integrated,
person-centred care as well as joined-up working to which the
National Health Service (NHS) aspires. Whether a child receives
rescue medication at school currently depends mostly on the
goodwill and resources available at each school. Consequently,
some children are effectively denied their basic legal right to
mainstream education, a clearly unacceptable situation.
This situation is not unique to the UK25 and some possible
ways forward are suggested in box 2. They include: greater use
of training resources for schools available from epilepsy volun-
tary sector organisations; consistent, practical information to
schools; transparent guidance outlining a clear care pathway
from the hospital to the school; and implementation and adher-
ence to each child’s individual healthcare plan.
Of course, the recommendations outlined above are not only
relevant to children with epilepsy. Lack of support from schools
is thought to be the main reason why diabetes specialists refrain
from prescribing certain forms of insulin to children in the
UK.26 And across Europe, organisations representing the inter-
ests of children with asthma, diabetes, epilepsy and anaphylaxis
have joined forces to campaign for greater recognition of the
medical needs of children with these conditions in schools (eg,
http://www.medicalconditionsatschool.org.uk).
It is important to recognise that inadequacies in the current
system are due to lack of resources and unclear guidance as
opposed to lack of good will or professionalism on the part of
schools and healthcare professionals. There are many promising
Box 1 Summary of recommendations in existing national
guidance on the management of medicines in schools11–13
▸ Parents submit a request to the school for their child to
receive prescribed medication as needed. They provide all
the necessary medical information from the treating
physician.
▸ An individualised healthcare plan is agreed among the
parents, school head, local health service and school doctor
or nurse (if available).
▸ This is supported by a school policy on the administration of
medicines and/or epilepsy.
▸ Teachers (or other staff members) are asked to volunteer to
take responsibility for administering the medication in
question.
▸ They receive speciﬁc training to do so either from the school
nurse or local health service.
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examples of primary care trusts working together with local
educational authorities to ﬁnd workable and sustainable solu-
tions. As changes to the NHS come into play and local services
become reconﬁgured, every effort should be made to maintain
such collaborations. And more needs to be done generally to
plan good epilepsy services at the local level, a point made
evident in the 2013 Epilepsy Action survey and raised subse-
quently in the House of Commons.2
Limited resources will be an ongoing issue. Yet somehow, we
need to ensure that the needs of children at risk of prolonged
convulsive seizures are met in a similar manner regardless of
where they go to school. As was expressed by a group of
parents of children with diabetes: ‘Every child matters—or do
they?’27 For the sake of all children who require medical assist-
ance at school, this is not a question we wish to be asking our-
selves in years to come.
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